B. Bulbul Et Al. , "Real-World Predictors of Survival in CDK4/6 Inhibitor-Treated Metastatic Breast Cancer: The Significance of ER Expression Level and Treatment Naivety," CURRENT ONCOLOGY , vol.32, no.12, 2025
Bulbul, B. Et Al. 2025. Real-World Predictors of Survival in CDK4/6 Inhibitor-Treated Metastatic Breast Cancer: The Significance of ER Expression Level and Treatment Naivety. CURRENT ONCOLOGY , vol.32, no.12 .
Bulbul, B., Ucun, B., Cangur, C., Yegen, I. T., Eren, O. O., Yilmaz, C., ... Gul, G.(2025). Real-World Predictors of Survival in CDK4/6 Inhibitor-Treated Metastatic Breast Cancer: The Significance of ER Expression Level and Treatment Naivety. CURRENT ONCOLOGY , vol.32, no.12.
Bulbul, Busra Et Al. "Real-World Predictors of Survival in CDK4/6 Inhibitor-Treated Metastatic Breast Cancer: The Significance of ER Expression Level and Treatment Naivety," CURRENT ONCOLOGY , vol.32, no.12, 2025
Bulbul, Busra Et Al. "Real-World Predictors of Survival in CDK4/6 Inhibitor-Treated Metastatic Breast Cancer: The Significance of ER Expression Level and Treatment Naivety." CURRENT ONCOLOGY , vol.32, no.12, 2025
Bulbul, B. Et Al. (2025) . "Real-World Predictors of Survival in CDK4/6 Inhibitor-Treated Metastatic Breast Cancer: The Significance of ER Expression Level and Treatment Naivety." CURRENT ONCOLOGY , vol.32, no.12.
@article{article, author={Busra Bulbul Et Al. }, title={Real-World Predictors of Survival in CDK4/6 Inhibitor-Treated Metastatic Breast Cancer: The Significance of ER Expression Level and Treatment Naivety}, journal={CURRENT ONCOLOGY}, year=2025}